Speakers
Klaus Rose, MD, MS
Chief Executive Officer, klausrose Consulting, Switzerland
Klaus Rose, a German MD with postgraduate degrees in General & Pharmaceutical Medicine, was 20 years with Big Pharma. In 2001, he became Global Head Pediatrics at Novartis & 2005 at Roche ; CEO of klausrose Consulting since 2011. He advises on pediatric drug development and FDA/EMA pediatric requirements. Private interests: languages, classical guitar, cooking, wine & gardening
Stephen P. Spielberg, MD, PhD
Editor-in-Chief, DIA, United States
Dr. Spielberg is Editor-in-Chief of DIA Publications. He has served in: academic medicine (pediatrics and pharmacology), and Dean of Dartmouth Medical School; in the pharmaceutical industry; and most recently as Deputy Commissioner for Medical Products and Tobacco at the US FDA.
Philip D. Walson, MD
Visiting Professor, Dept. Clinical Chemistry, University Medical Center Goettingen, Germany
AB-Chemistry-U.of CalifBerkeley MD-Univ.California,San Francisco (UCSF) PedsU.Chicago ClinPharmacology Fellowship UCSF Assist/Assoc.Prof Peds, Pharmacol. Pharmacy,U.Arizona 1973-81 Prof. Peds,Pharmacol & Pharmacy,the Ohio State Univ.1981-2000 ProfPedsPharmacol &Pharmacy-Univ Cincinnati 2000-2008
Have an account?
Ways to register
Archived Webinar
Series Discount Available*
Buy 3 or more webinars in this series and save 15%
Buy 5 or more and save 20%
Buy the whole series and save 30%
*Order must be placed in one transaction for savings to be applied.
Individual registration is a license for ONE internet login allowing one viewer.
Group site registration is a license for ONE internet login allowing multiple viewers from one location.
Group Plus is a license for up to FIVE internet logins allowing one or more viewers at each login location.
CANCELLATIONS
No refunds will be provided in the event of a participant’s cancellation since all costs for this webinar have been prepaid by DIA. DIA reserves the right to modify or cancel programs and/or substitute presenters or panelists. DIA is not responsible for failure to deliver programs due to circumstances beyond its control.
Participants with Disabilities: Reasonable accommodations will be made available to persons with disabilities who attend an educational activity. Contact the DIA office in writing at least 15 days prior to event to indicate your needs.